Bandaram Pharma Packtech Closes Trading Window for Q2 FY27 Results
Bandaram Pharma Packtech Limited has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from October 1, 2026, and will remain in effect until 48 hours after the declaration of the standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. A board meeting is scheduled to approve these financial results, with a separate intimation to be sent to the stock exchange regarding the meeting notice. Designated persons and connected individuals are prohibited from trading during this period.
Key Highlights
- Trading window closed from Oct 1, 2026, for Q2 FY27 results.
- Closure lasts until 48 hours post-financial results declaration.
- Aims to comply with SEBI Insider Trading Regulations.
- Board meeting to approve Q2 FY27 financial results scheduled.
- Designated persons restricted from trading securities.
Price Impact
More from BANDARAM